Our Commitment to Innovation & Research
"A paradigm shift from reactive disease care to proactive health care is underway. And the distinction between diagnostics, devices, and drugs used for optimizing wellness versus managing disease is blurring.
We applaud the growing consumer instinct to seek greater agency over one’s well-being and longevity. And we are excited by the potential of platforms like Restore to support the democratization, dissemination, and delivery of health solutions outside of traditional healthcare settings.
We are committed to helping Restore lead this paradigm shift boldly and thoughtfully—by developing rigorous clinical standards, identifying safe and effective products and protocols, and advancing the science behind its innovative therapies and modalities."
.png)
Dr. Henry Legere
.png)
Dr. Rachele Pojednic
.jpg)
Dr. Henry Legere
Chief Medical Officer
Dr. Henry Legere founded the second-largest clinical allergy practice and research center, and his team is known for its medical technology innovation and advanced protocols. Dr. Legere has 50 awarded patents and 25+ pending.
Dr. Rachele Pojednic
Chief Science Officer
Dr. Rachele Pojednic is an international authority on nutrition, supplementation and physical activity interventions for muscle physiology, performance and recovery.
.webp)
